SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
cxccx
Lv1
30 积分
2023-04-20 加入
最近求助
最近应助
互助留言
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma
6小时前
已完结
Therapeutic developments in pancreatic cancer
1年前
已完结
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
1年前
已完结
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
1年前
已完结
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study
1年前
已完结
Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation
1年前
已关闭
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study
1年前
已完结
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study
1年前
已完结
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
2年前
已完结
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
2年前
已关闭
没有进行任何应助
感谢
6小时前
感谢
1年前
此版本为2007版本,需要2023版本
1年前
2023年新发布的版本没有吗?
1年前
感谢
1年前
感谢
1年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论